Recombinant Human ALCAM
- -
- -
BackgroundThis protein is a member of the immunoglobulin gene superfamily expressed by leukocytes after cell activation and thymic epithelial cells. In the nomenclature of CD antigens this protein has been given the designation CD166. ALCAM is a ligand for the lymphocyte antigen CD6 but also engages in homophilic interactions. Mouse ALCAM shows an overall identity of 93 % with the human protein. ALCAM has been identified independently as MEMD. mRNA transcripts encoding murine ALCAM are expressed in the brain, lung, liver, and the kidney, as well as by activated leukocytes and a number of cell lines. A rat monoclonal antibody specific for murine ALCAM binds to both activated CD4(+) and CD8(+) T-cells. The antigen is expressed on natural killer cells, thymocytes, platelets, B-cells and T-cells after cell activation, eosinophils, fibroblasts, endothelial cells, keratinocytes, monocytes after cell activation, neurons. The ligand for CD166 is CD6. Protein DetailsPurity >95% by SDS-PAGE and analyzed by silver stain. Endotoxin Level <0.1 EU/µg as determined by the LAL method Biological Activity The biological activity of Human ALCAM was determined by its ability to block adhesion of HUT-78, a human cutaneous T cell lymphoma, to immobilized recombinant human CD6/Fc protein. Recombinant human ALCAM/Fc at 5 μg/ml (50 μl/well) blocked 100% of HUT-78 cell adhesion (1 x 10<sup>6</sup> cells/ml, 50 μl/well) to 10 μg/ml (100 μl/well, immobilized) recombinant human CD6/Fc. Fusion Protein Tag Fc Fusion Protein Protein Accession No. Amino Acid Sequence wyt vnsaygdtii ipcrldvpqn lmfgkwkyek pdgspvfiaf rsstkksvqy ddvpeykdrl nlsenytlsi snarisdekr fvcmlvtedn vfeaptivkv fkqpskpeiv skalfleteq lkklgdcise dsypdgnitw yrngkvlhpl egavviifkk emdpvtqlyt mtstleyktt kadiqmpftc svtyygpsgq ktihseqavf diyypteqvt iqvlppknai kegdnitlkc lgngnpppee flfylpgqpe girssntytl mdvrrnatgd ykcslidkks miastaitvh yldlslnpsg evtrqigdal pvsctisasr natvvwmkdn irlrsspsfs slhyqdagny vcetalqeve glkkresltl ivegkpqikm tkktdpsgls ktiichvegf pkpaiqwtit gsgsvinqte espyingryy skiiispeen vtltctaenq lertvnslnv saisipehde adeisdenre kvndqadieg rmdpkscdkt htcppcpape llggpsvflf ppkpkdtlmi srtpevtcvv vdvshedpev kfnwyvdgve vhnaktkpre eqynstyrvv svltvlhqdw lngkeykckv snkalpapie ktiskakgqp repqvytlpp srdeltknqv sltclvkgfy psdiavewes ngqpennykt tppvldsdgs fflyskltvd ksrwqqgnvf scsvmhealh nhytqkslsl spgkhhhhhh N-terminal Sequence Analysis Trp28 State of Matter Lyophilized Predicted Molecular Mass The predicted molecular weight of Recombinant Human ALCAM is Mr 83.5 kDa. However, the actual molecular weight as observed by migration on SDS Page is Mr 120 kDa. Predicted Molecular Mass 83.5 Formulation This recombinant protein was 0.2 µm filtered and lyophilized from modified Dulbecco’s phosphate buffered saline (1X PBS) pH 7.2 – 7.3 with no calcium, magnesium, or preservatives. Storage and Stability This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution, this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions. Country of Origin USA Shipping Next Day Ambient NCBI Gene Bank Technical ProtocolsCertificate of AnalysisIMPORTANT Use lot specific datasheet for all technical information pertaining to this recombinant protein. |
Related Products
